SELNECITY
79398416
US
SELNECITY
REQUEST FOR EXTENSION OF TIME TO FILE OPPOSITION
005
HER2.M+
99012962
US
HER2.M+
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
042
EMPA-REG MIDI
79138474
US
EMPA-REG MIDI
PARTIAL SECTION 71 ACCEPTED
041, 042
EMPA-REG PIO
79138325
US
EMPA-REG PIO
PARTIAL SECTION 71 ACCEPTED
041, 042
SEVWELQ
79402395
US
SEVWELQ
NON-FINAL ACTION COUNTED - NOT MAILED
005
EASI-HTN
79418093
US
EASI-HTN
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
042
LogoMark
79417978
US
LogoMark
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
009, 044
FLITEPATH
79417979
US
FLITEPATH
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
009, 044
INMOTION
98072578
US
INMOTION
FIRST EXTENSION - GRANTED
042
LIFE FORWARD
79363829
US
LIFE FORWARD
REGISTERED
001, 003, 005, 009, 010, 031, 041, 042
HER2.M+
79415139
US
HER2.M+
NON-FINAL ACTION COUNTED - NOT MAILED
042
LIVERAGE
79409063
US
LIVERAGE
NON-FINAL ACTION COUNTED - NOT MAILED
042
EASI-HF
79402638
US
EASI-HF
RESPONSE AFTER NON-FINAL ACTION - ENTERED
042
VARGATEF
98338867
US
VARGATEF
FIRST EXTENSION - GRANTED
005
NECSELLTRI
79398421
US
NECSELLTRI
IR CANCELLED - NO TRANSFORMATION FILED
005
CARMELINA
79137536
US
CARMELINA
Section 71 & 15 – ACCEPTED AND ACKNOWLEDGED
041
LogoMark
79419113
US
LogoMark
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
009, 044
ARBRELLA
79418801
US
ARBRELLA
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
009, 044
EMPA-REG EXTEND
79138319
US
EMPA-REG EXTEND
Section 71 & 15 – ACCEPTED AND ACKNOWLEDGED
041
EMPEROR HEART FAILURE STUDIES
UK00801373345
UK
EMPEROR HEART FAILURE STUDIES
42, 41
Getting to the heart of type 2 diabetes
UK00917557307
UK
Getting to the heart of type 2 diabetes
44, 9
EMPRISE EMPAGLIFLOZIN REAL-WORLD EFFECTIVENESS
UK00801444233
UK
EMPRISE EMPAGLIFLOZIN REAL-WORLD EFFECTIVENESS
42